Prevalence and Implications of Significance Testing for Baseline Covariate Imbalance in Randomised Cancer Clinical Trials

Sherry, A. D., Msaouel, P., McCaw, Z. R., Abi Jaoude, J., Hsu, E. J., Kouzy, R., Patel, R., et al. (2023). Prevalence and Implications of Significance Testing for Baseline Covariate Imbalance in Randomised Cancer Clinical Trials: The Table 1 Fallacy. European Journal of Cancer.

Type

Journal article

Intellectual base

Primary research

Year

2023

DOI

10.1016/j.ejca.2023.113357

DOI registrant

Elsevier

Link

https://doi.org/10.1016/j.ejca.2023.113357

Cited by

1 citation across 1 artifact.

Each citation links to the sentence it supports in the citing article.

Mechanisms

• Completer Balance Table
  • The classic misuse is the Table 1 fallacy

    This sourceDefines the Table 1 fallacy as testing baseline differences and treating non-significance as balance, although P values do not measure the magnitude or clinical importance of imbalance.

Verification

Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.

Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.

Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.

See how references were verified.

Registry ID ref:13c971244a84 · see in the full table